Abstract:Background: T lymphocyte achieves an immune response by recognizing antigen peptides (also known as T cell epitopes) through major histocompatibility complex (MHC) molecules. The immunogenicity of T cell epitopes depends on their source and stability in combination with MHC molecules. The binding of the peptide to MHC is the most selective step, so predicting the binding affinity of the peptide to MHC is the principal step in predicting T cell epitopes. The identification of epitopes is of great significance in the research of vaccine design and T cell immune response. Objective: The traditional method for identifying epitopes is to synthesize and test the binding activity of peptide by experimental methods, which is not only time-consuming, but also expensive. In silico methods for predicting peptide-MHC binding emerge to pre-select candidate peptides for experimental testing, which greatly saves time and costs. By summarizing and analyzing these methods, we hope to have a better insight and provide guidance for future directions. Methods: Up to now, a number of methods have been developed to predict the binding ability of peptides to MHC based on various principles. Some of them employ matrix models or machine learning models based on the sequence characteristic embedded in peptides or MHC to predict the binding ability of peptides to MHC. Some others utilize the three-dimensional structural information of peptides or MHC, for example, by extracting three-dimensional structural information to construct a feature matrix or machine learning model, or directly using protein structure prediction, molecular docking to predict the binding mode of peptides and MHC. Results: Although the methods in predicting peptide-MHC binding based on the feature matrix or machine learning model can achieve high-throughput prediction, the accuracy of which depends heavily on the sequence characteristic of confirmed binding peptides. In addition, it cannot provide insights into the mechanism of antigen specificity. Therefore, such methods have certain limitations in practical applications. Methods in predicting peptide-MHC binding based on structural prediction or molecular docking are computationally intensive compared to the methods based on feature matrix or machine learning model and the challenge is how to predict a reliable structural model. Conclusion: This paper reviews the principles, advantages and disadvantages of the methods of peptide-MHC binding prediction and discussed the future directions to achieve more accurate predictions.

A transformer-based model to predict peptide–HLA class I binding and optimize mutated peptides for vaccine design

TransMut: a Program to Predict HLA-I Peptide Binding and Optimize Mutated Peptides for Vaccine Design by the Transformer-derived Self-Attention Model

Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy

Machine learning application to predict binding affinity between peptide containing non-canonical amino acids and HLA0201

A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction

Ranking-based Convolutional Neural Network Models for Peptide-MHC Binding Prediction

Guiding a language-model based protein design method towards MHC Class-I immune-visibility profiles for vaccines and therapeutics

HLA class I binding prediction via convolutional neural networks

Machine Learning Methods for Predicting HLA-Peptide Binding Activity.

Peptide-Major Histocompatibility Complex Class I Binding Prediction Based on Deep Learning with Novel Feature.

A comprehensive assessment and comparison of tools for HLA class I peptide-binding prediction

CapHLA: a comprehensive tool to predict peptide presentation and binding to HLA class I and class II

Enhancing antigenic peptide discovery: Improved MHC-I binding prediction and methodology

TripHLApan: predicting HLA molecules binding peptides based on triple coding matrix and transfer learning

A novel kernel-based approach for predicting binding peptides for HLA class II molecules

Prediction of MHC-binding Peptides of Flexible Lengths from Sequence-Derived Structural and Physicochemical Properties

STMHCpan, an Accurate Star-Transformer-based Extensible Framework for Predicting MHC I Allele Binding Peptides.

Pep2Vec: An Interpretable Model for Peptide-MHC Presentation Prediction and Contaminant Identification in Ligandome Datasets

HLAB: Learning the BiLSTM Features from the ProtBert-encoded Proteins for the Class I HLA-peptide Binding Prediction.

A Review on the Methods of Peptide-MHC Binding Prediction

Integrating Reinforcement Learning and Monte Carlo Tree Search for enhanced neoantigen vaccine design